• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有心血管疾病的医疗保险患者慢性肾病患病率高,且进展为终末期肾病的比例也高。

Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease.

作者信息

McClellan William M, Langston Robert D, Presley Rodney

机构信息

Georgia Medical Care Foundation, Atlanta, Georgia 30346, USA.

出版信息

J Am Soc Nephrol. 2004 Jul;15(7):1912-9. doi: 10.1097/01.asn.0000129982.10611.4c.

DOI:10.1097/01.asn.0000129982.10611.4c
PMID:15213281
Abstract

The risk of progression to ESRD among individuals with cardiovascular disease and chronic kidney disease (CKD) is not well defined. The purpose of this study was to describe the risk of ESRD among patients with cardiovascular disease. Charts were abstracted for randomly selected hospitalized Medicare beneficiaries with a diagnosis of either congestive heart failure (CHF) or acute myocardial infarction (AMI). The prevalence of CKD, based on the estimated modified diet in renal disease GFR of <60 ml/min per m2, was 60.4% of CHF patients and 51.7% of AMI patients. When compared with patients without CKD, the 30-d readmission rate was higher for CHF patients with CKD (odds ratio [OR], 1.70; 95% confidence interval [CI], 1.18 to 2.44) and for AMI patients with CKD (OR, 1.78; 95% CI, 1.17 to 2.70). CHF patients (OR, 1.62; 95% CI, 1.15 to 2.30) and AMI patients (OR, 3.10; 95% CI, 1.98 to 4.84) with CKD were more likely to die during the year after discharge from the hospital. ESRD after discharge occurred in nine of 517 patients with AMI and 24 of 640 patients with CHF. CKD increased the risk of ESRD among CHF patients (OR, 34.5; 95% CI, 4.23 to 279.43) and AMI patients (0 and 3% for those without and with CKD, respectively). At discharge, 18% of AMI patients and 21% of CHF patients with CKD were discharged with a diagnosis of renal disease. CKD is highly prevalent among patients with cardiovascular disease and is associated with increased risk of adverse outcomes, including progression to ESRD. This study suggests that opportunities may exist to improve the detection of CKD in these patients who are hospitalized with cardiovascular disease.

摘要

心血管疾病和慢性肾脏病(CKD)患者进展为终末期肾病(ESRD)的风险尚不明确。本研究的目的是描述心血管疾病患者发生ESRD的风险。对随机选取的诊断为充血性心力衰竭(CHF)或急性心肌梗死(AMI)的住院医疗保险受益人病历进行了摘要分析。根据估计的肾脏病改良饮食公式计算的肾小球滤过率(GFR)<60 ml/(min·m²),CKD在CHF患者中的患病率为60.4%,在AMI患者中为51.7%。与无CKD的患者相比,有CKD的CHF患者30天再入院率更高(比值比[OR],1.70;95%置信区间[CI],1.18至2.44),有CKD的AMI患者也是如此(OR,1.78;95%CI,1.17至2.70)。有CKD的CHF患者(OR,1.62;95%CI,1.15至2.30)和AMI患者(OR,3.10;95%CI,1.98至4.84)在出院后一年内死亡的可能性更大。出院后,517例AMI患者中有9例发生ESRD,640例CHF患者中有24例发生ESRD。CKD增加了CHF患者发生ESRD的风险(OR,34.5;95%CI,4.23至279.43)以及AMI患者发生ESRD的风险(无CKD者为0,有CKD者为3%)。出院时,18%的有CKD的AMI患者和21%的有CKD的CHF患者出院诊断为肾病。CKD在心血管疾病患者中非常普遍,并且与不良结局风险增加相关,包括进展为ESRD。本研究表明,对于这些因心血管疾病住院的患者,可能存在改善CKD检测的机会。

相似文献

1
Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease.患有心血管疾病的医疗保险患者慢性肾病患病率高,且进展为终末期肾病的比例也高。
J Am Soc Nephrol. 2004 Jul;15(7):1912-9. doi: 10.1097/01.asn.0000129982.10611.4c.
2
Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR.在估算肾小球滤过率降低的患者中,房颤事件与充血性心力衰竭、心肌梗死、终末期肾病和死亡的风险。
Am J Kidney Dis. 2018 Feb;71(2):191-199. doi: 10.1053/j.ajkd.2017.08.016. Epub 2017 Nov 16.
3
Thiazide and thiazide-like diuretics are associated with improved cardiovascular and renal outcomes in patients with chronic kidney disease.噻嗪类和噻嗪样利尿剂可改善慢性肾脏病患者的心血管和肾脏结局。
Ann Acad Med Singap. 2023 Oct 30;52(10):510-521. doi: 10.47102/annals-acadmedsg.202359.
4
Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.透析前慢性肾脏病中心血管疾病的临床流行病学
Semin Dial. 2003 Mar-Apr;16(2):101-5. doi: 10.1046/j.1525-139x.2003.16025.x.
5
Magnitude of rate of change in kidney function and future risk of cardiovascular events.肾功能变化率的幅度与未来心血管事件风险
Int J Cardiol. 2016 Jan 1;202:657-65. doi: 10.1016/j.ijcard.2015.09.090. Epub 2015 Sep 28.
6
Impact of chronic kidney disease and end-stage renal disease on the mid-term adverse outcomes in diabetic patients with cardiovascular diseases.慢性肾脏病和终末期肾病对合并心血管疾病的糖尿病患者中期不良结局的影响。
Sci Rep. 2024 Jul 9;14(1):15770. doi: 10.1038/s41598-024-66655-0.
7
Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular disease.老年主要心血管疾病患者常见的非心血管多病种分组与临床结局。
J Am Geriatr Soc. 2023 Oct;71(10):3179-3188. doi: 10.1111/jgs.18479. Epub 2023 Jun 24.
8
Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.老年慢性肾脏病患者:5 年随访后的结局。
Nefrologia. 2012 May 14;32(3):300-5. doi: 10.3265/Nefrologia.pre2012.Jan.10994. Epub 2012 Feb 28.
9
Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.比较使用 CKD-EPI 和 MDRD 研究 GFR 估算方程的 CKD 患病率和死亡率风险:AusDiab(澳大利亚糖尿病、肥胖和生活方式)研究。
Am J Kidney Dis. 2010 Apr;55(4):660-70. doi: 10.1053/j.ajkd.2009.12.011.
10
Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.慢性肾脏病进展与心血管疾病之间的关联:CRIC研究结果
Am J Nephrol. 2014;40(5):399-407. doi: 10.1159/000368915. Epub 2014 Nov 11.

引用本文的文献

1
Impact of chronic kidney disease and end-stage renal disease on the mid-term adverse outcomes in diabetic patients with cardiovascular diseases.慢性肾脏病和终末期肾病对合并心血管疾病的糖尿病患者中期不良结局的影响。
Sci Rep. 2024 Jul 9;14(1):15770. doi: 10.1038/s41598-024-66655-0.
2
Association between bilirubin and chronic kidney disease in hypertensive patients: The China hypertension registry study.胆红素与高血压患者慢性肾脏病的关系:中国高血压登记研究。
J Clin Hypertens (Greenwich). 2023 Dec;25(12):1185-1192. doi: 10.1111/jch.14727. Epub 2023 Nov 20.
3
Non-Diabetic Kidney Disease in Type 2 Diabetes Mellitus: A Changing Spectrum with Therapeutic Ascendancy.
2型糖尿病中的非糖尿病性肾病:治疗优势下不断变化的疾病谱
J Clin Med. 2023 Feb 20;12(4):1705. doi: 10.3390/jcm12041705.
4
Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals: A Randomized Clinical Trial.检测和披露与肾功能衰竭相关的特定种族遗传风险对患者和医疗保健专业人员的影响:一项随机临床试验。
JAMA Netw Open. 2022 Mar 1;5(3):e221048. doi: 10.1001/jamanetworkopen.2022.1048.
5
Chronic kidney disease: prevalence and association with handgrip strength in a cross-sectional study.慢性肾脏病:横断面研究中的患病率及与握力的关系。
BMC Nephrol. 2021 Jul 2;22(1):246. doi: 10.1186/s12882-021-02452-5.
6
Cardiovascular Risk Assessment Using Ultrasonographic Surrogate Markers of Atherosclerosis and Arterial Stiffness in Patients With Chronic Renal Impairment: A Narrative Review of the Evidence and a Critical View of Their Utility in Clinical Practice.使用超声替代标志物评估慢性肾功能损害患者的动脉粥样硬化和动脉僵硬度的心血管风险:证据的叙述性综述及其在临床实践中的效用批判性观点
Can J Kidney Health Dis. 2020 Sep 10;7:2054358120954939. doi: 10.1177/2054358120954939. eCollection 2020.
7
Renal dysfunction in cardiovascular diseases and its consequences.心血管疾病中的肾功能障碍及其后果。
J Nephrol. 2021 Feb;34(1):137-153. doi: 10.1007/s40620-020-00842-w. Epub 2020 Sep 1.
8
Impact of cardiovascular events on mortality and progression of renal dysfunction in a Queensland CKD cohort.昆士兰慢性肾脏病队列中心血管事件对死亡率和肾功能障碍进展的影响。
Nephrology (Carlton). 2020 Nov;25(11):839-844. doi: 10.1111/nep.13745. Epub 2020 Jul 1.
9
Interactive association of baseline and changes in serum uric acid on renal dysfunction among community-dwelling persons.社区居民中血清尿酸基线和变化与肾功能障碍的交互关联。
J Clin Lab Anal. 2020 May;34(5):e23166. doi: 10.1002/jcla.23166. Epub 2019 Dec 27.
10
Prognostic Impact of Chronic Kidney Disease in Patients with Heart Failure.慢性肾脏病对心力衰竭患者的预后影响
Perm J. 2019;23. doi: 10.7812/TPP/18.273. Epub 2019 Sep 5.